表紙:3D細胞培養の世界市場:製品・アプリケーション・エンドユーザー別の市場機会分析および業界予測(2020年~2027年)
市場調査レポート
商品コード
975018

3D細胞培養の世界市場:製品・アプリケーション・エンドユーザー別の市場機会分析および業界予測(2020年~2027年)

3D Cell Culture Market by Product, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 231 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
3D細胞培養の世界市場:製品・アプリケーション・エンドユーザー別の市場機会分析および業界予測(2020年~2027年)
出版日: 2020年10月10日
発行: Allied Market Research
ページ情報: 英文 231 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞培養は生物学的研究における重要なツールです。これらの培養は主に2つのタイプ、すなわち2次元(2D)と3次元(3D)です。細胞培養技術の出現以来、2D細胞培養は、その入手可能性、環境制御の容易さ、細胞の観察および測定のために最も好まれています。ただし、表面の平らな層で細胞を成長させることは、生体内の状態を正確にモデル化するものではありません。 2Dと比較すると、3D細胞培養では、生体細胞が成長し、3次元すべてで周囲と相互作用することができます。 3D細胞培養モデルで増殖した細胞は、生理学的に関連性があることが証明されています。それらは、細胞形態、増殖、分化、細胞数モニタリング、生存率、腫瘍細胞の周囲組織への移動および浸潤、刺激への反応、血管新生刺激、薬物代謝、遺伝子発現およびタンパク質合成、免疫系の回避、生体内の関連性などの生物学的メカニズムの多くの研究において改善を示しています。したがって、3D細胞培養は、病因の研究と分析に有益で、研究分野での採用が促進されています。

世界の3D細胞培養の市場規模は、2019年に12億3,486万米ドルと評価され、予測期間中に16.3%のCAGRで拡大し、2027年までに37億2,168万米ドルに達すると予測されています。この成長率は主に、細胞間および細胞間相互作用において、従来の2D細胞培養よりも3D細胞培養によって提供される利点に起因します。また、創薬、開発およびスクリーニングのための研究開発活動における継続的な努力、および癌調査における3D細胞培養の使用への傾向は、分析期間にわたって市場の成長を推進すると予想される更なる要因となっています。同様に、臓器移植の需要の急増は、3D細胞培養市場の成長にプラスの影響を与えると予測されています。逆に、3D細胞培養の実装に関連するより高いコストと結果に一貫性のない点が、市場成長を妨げています。一方、3D細胞培養の分野で製品の進化につながる今後の技術は、市場の主要参入企業に有益な成長機会を提供すると推定されています。さらに、3D細胞培養業界は現在、COVID-19のパンデミックにより、3D細胞培養コンポーネントの需要と供給に対処するための新たな課題に直面しています。その上、一貫性のない中断されたサプライチェーン活動と人材の利用可能性が市場成長に影響を与えると予想されます。それにも関わらず、COVID-19に対する新しい治療法を開発するための研究実践の急増は、主要な市場参入企業にとって大きな機会となっています。幹細胞治療と再生医療に関連する研究は、COVID-19の治療に有望な結果を示しています。そのため、これは世界的なロックダウンによって引き起こされている有害な影響を補償することが期待されています。したがって、全体的なCOVID-19の影響は、3D細胞培養市場の有名企業にとって中程度にとどまると予想されています。

当レポートでは、世界の3D細胞培養市場を調査し、市場の概要、製品・アプリケーション・エンドユーザー・地域別の市場規模の推移と予測、市場動向、成長促進要因および抑制要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
    • 主な成功戦略
  • 特許分析
    • 特許分析:年別
    • 特許分析:国別
  • 市場力学
    • 成長促進要因
      • 2D技術に対する3D培養技術のメリット
      • 研究開発活動への投資の伸び
      • 癌研究のための3D細胞培養への選好のシフト
      • 臓器移植需要の急増
    • 抑制要因
      • 高い実装コスト
      • 3D細胞培養の結果の不規則性
    • 市場機会
      • 技術の進歩
  • COVID-19影響分析

第4章 3D細胞培養市場:製品別

  • 概要
    • 市場規模と予測
  • 足場ベースのプラットフォーム
    • 主要な市場動向と成長機会
    • 市場規模と予測
    • 市場分析:国別
    • 足場ベースのプラットフォーム市場:タイプ別
      • マクロ多孔質足場
      • マイクロ多孔質足場
      • ナノ多孔質足場
      • 固体足場
  • 足場のないプラットフォーム
    • 主要な市場動向と成長機会
    • 市場規模と予測
    • 市場分析:国別
  • ジェル
    • 主要な市場動向と成長機会
    • 市場規模と予測
    • 市場分析:国別
  • バイオリアクター
    • 主要な市場動向と成長機会
    • 市場規模と予測
    • 市場分析:国別
  • マイクロチップ
    • 主要な市場動向と成長機会
    • 市場規模と予測
    • 市場分析:国別
  • サービス
    • 主要な市場動向と成長機会
    • 市場規模と予測
    • 市場分析:国別

第5章 3D細胞培養市場:アプリケーション別

  • 概要
    • 市場規模と予測
  • 癌研究
    • 市場規模と予測
    • 市場分析:国別
  • 幹細胞調査
    • 市場規模と予測
    • 市場分析:国別
  • 創薬
    • 市場規模と予測
    • 市場分析:国別
  • 再生医療
    • 市場規模と予測
    • 市場分析:国別

第6章 3D細胞培養市場:エンドユーザー別

  • 概要
    • 市場規模と予測
  • バイオテクノロジーおよび製薬企業
    • 市場規模と予測
    • 市場分析:国別
  • 委託研究所
    • 市場規模と予測
    • 市場分析:国別
  • 学術機関
    • 市場規模と予測
    • 市場分析:国別

第7章 3D細胞培養市場:地域別

  • 概要
    • 市場規模と予測
  • 北米
    • 主要な市場動向と機会
    • 市場規模と予測:国別
    • 北米の3D細胞培養市場:製品別
    • 北米の3D細胞培養市場:アプリケーション別
    • 北米の3D細胞培養市場:エンドユーザー別
    • 米国
      • 米国の3D細胞培養市場:製品別
      • 米国の3D細胞培養市場:アプリケーション別
      • 米国の3D細胞培養市場:エンドユーザー別
    • カナダ
      • カナダの3D細胞培養市場:製品別
      • カナダの3D細胞培養市場:アプリケーション別
      • カナダの3D細胞培養市場:エンドユーザー別
    • メキシコ
      • メキシコの3D細胞培養市場:製品別
      • メキシコの3D細胞培養市場:アプリケーション別
      • メキシコの3D細胞培養市場:エンドユーザー別
  • 欧州
    • 主要な市場動向と機会
    • 市場規模と予測:国別
    • 欧州の3D細胞培養市場:製品別
    • 欧州の3D細胞培養市場:アプリケーション別
    • 欧州の3D細胞培養市場:エンドユーザー別
    • ドイツ
      • ドイツの3D細胞培養市場:製品別
      • ドイツの3D細胞培養市場:アプリケーション別
      • ドイツの3D細胞培養市場:エンドユーザー別
    • フランス
      • フランスの3D細胞培養市場:製品別
      • フランスの3D細胞培養市場:アプリケーション別
      • フランスの3D細胞培養市場:エンドユーザー別
    • 英国
      • 英国の3D細胞培養市場:製品別
      • 英国の3D細胞培養市場:アプリケーション別
      • 英国の3D細胞培養市場:エンドユーザー別
    • その他欧州
      • その他欧州の3D細胞培養市場:製品別
      • その他欧州の3D細胞培養市場:アプリケーション別
      • その他欧州の3D細胞培養市場:エンドユーザー別
  • アジア太平洋地域
    • 主要な市場動向と機会
    • 市場規模と予測:国別
    • アジア太平洋地域の3D細胞培養市場:製品別
    • アジア太平洋地域の3D細胞培養市場:アプリケーション別
    • アジア太平洋地域の3D細胞培養市場:エンドユーザー別
    • 日本
      • 日本の3D細胞培養市場:製品別
      • 日本の3D細胞培養市場:アプリケーション別
      • 日本の3D細胞培養市場:エンドユーザー別
    • 中国
      • 中国の3D細胞培養市場:製品別
      • 中国の3D細胞培養市場:アプリケーション別
      • 中国の3D細胞培養市場:エンドユーザー別
    • インド
      • インドの3D細胞培養市場:製品別
      • インドの3D細胞培養市場:アプリケーション別
      • インドの3D細胞培養市場:エンドユーザー別
    • オーストラリア
      • オーストラリアの3D細胞培養市場:製品別
      • オーストラリアの3D細胞培養市場:アプリケーション別
      • オーストラリアの3D細胞培養市場:エンドユーザー別
    • その他アジア太平洋地域
      • その他アジア太平洋地域の3D細胞培養市場:製品別
      • その他アジア太平洋地域の3D細胞培養市場:アプリケーション別
      • その他アジア太平洋地域の3D細胞培養市場:エンドユーザー別
  • LAMEA
    • 主要な市場動向と機会
    • 市場規模と予測:国別
    • LAMEA 3D細胞培養市場:製品別
    • LAMEA 3D細胞培養市場:アプリケーション別
    • LAMEA 3D細胞培養市場:エンドユーザー別
    • ブラジル
      • ブラジルの3D細胞培養市場:製品別
      • ブラジルの3D細胞培養市場:アプリケーション別
      • ブラジルの3D細胞培養市場:エンドユーザー別
    • サウジアラビア
      • サウジアラビアの3D細胞培養市場:製品別
      • サウジアラビアの3D細胞培養市場:アプリケーション別
      • サウジアラビアの3D細胞培養市場:エンドユーザー別
    • 南アフリカ
      • 南アフリカの3D細胞培養市場:製品別
      • 南アフリカの3D細胞培養市場:アプリケーション別
      • 南アフリカの3D細胞培養市場:エンドユーザー別
    • その他LAMEA
      • その他LAMEAの3D細胞培養市場部分:製品別
      • その他LAMEAの3D細胞培養市場の残りの部分:アプリケーション別
      • その他LAMEAの3D細胞培養市場の残りの部分:エンドユーザー別

第8章 企業プロファイル

  • 3D BIOTEK LLC
  • ADVANCED BIOMATRIX, INC.
  • AVANTOR, INC.
  • BECTON, DICKINSON AND COMPANY
  • CORNING INCORPORATED
  • INSPHERO AG
  • LONZA GROUP LTD.
  • MERCK & CO., INC.
  • SYNTHECON, INCORPORATED
  • THERMO FISHER SCIENTIFIC INC.
図表

LIST OF TABLES

  • TABLE 01.2D CELL CULTURES VS 3D CELL CULTURES
  • TABLE 02.ORGAN DONATION RATE, 2018
  • TABLE 03.3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 04.3D CELL CULTURE MARKET FOR SCAFFOLD-BASED PLATFORM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 05.SCAFFOLD-BASED PLATFORM SEGMENT, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 06.3D CELL CULTURE MARKET FOR SCAFFOLD-FREE PLATFORM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 07.3D CELL CULTURE MARKET FOR GELS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.3D CELL CULTURE MARKET FOR BIOREACTORS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.3D CELL CULTURE MARKET FOR MICROCHIPS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.3D CELL CULTURE MARKET FOR SERVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 12.3D CELL CULTURES MARKET FOR CANCER RESEARCH, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 17.3D CELL CULTURE MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 20.3D CELL CULTURE MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 21.NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 22.NORTH AMERICA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 23.NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 24.NORTH AMERICA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 25.U.S. 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 26.U.S. 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 27.U.S. 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 28.CANADA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 29.CANADA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 30.CANADA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 31.MEXICO 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 32.MEXICO 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 33.MEXICO 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 34.EUROPE 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 35.EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 36.EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 37.EUROPE 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 38.GERMANY 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 39.GERMANY 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 40.GERMANY 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 41.FRANCE 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 42.FRANCE 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 43.FRANCE 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 44.UK 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 45.UK 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 46.UK 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 47.REST OF EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 48.REST OF EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 49.U.S. 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 50.ASIA-PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 51.ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 52.ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 53.ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 54.JAPAN 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 55.JAPAN 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 56.JAPAN 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 57.CHINA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 58.CHINA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 59.CHINA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 60.INDIA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 61.INDIA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 62.INDIA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 63.AUSTRALIA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 64.AUSTRALIA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 65.AUSTRALIA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 66.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 67.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 68.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 69.LAMEA 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 70.LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 71.LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 72.LAMEA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 73.BRAZIL 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 74.BRAZIL 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 75.BRAZIL 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 76.SAUDI ARABIA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 77.SAUDI ARABIA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 78.SAUDI ARABIA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 79.SOUTH AFRICA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 80.SOUTH AFRICA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 81.SOUTH AFRICA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 82.REST OF LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 83.REST OF LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 84.REST OF LAMEA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 85.3D BIOTEK: COMPANY SNAPSHOT
  • TABLE 86.3D BIOTEK: OPERATING SEGMENTS
  • TABLE 87.ADVANCED BIOMATRIX: COMPANY SNAPSHOT
  • TABLE 88.ADVANCED BIOMATRIX: OPERATING SEGMENTS
  • TABLE 89.AVANTOR: COMPANY SNAPSHOT
  • TABLE 90.AVANTOR: OPERATING SEGMENTS
  • TABLE 91.BD: COMPANY SNAPSHOT
  • TABLE 92.BD: OPERATING SEGMENTS
  • TABLE 93.CORNING: COMPANY SNAPSHOT
  • TABLE 94.CORNING: OPERATING SEGMENTS
  • TABLE 95.INSPHERO: COMPANY SNAPSHOT
  • TABLE 96.INSPHERO: OPERATING SEGMENTS
  • TABLE 97.LONZA: COMPANY SNAPSHOT
  • TABLE 98.LONZA: OPERATING SEGMENTS
  • TABLE 99.MERCK: COMPANY SNAPSHOT
  • TABLE 100.MERCK: OPERATING SEGMENTS
  • TABLE 101.SYNTHECON: COMPANY SNAPSHOT
  • TABLE 102.THERMO FISHER: COMPANY SNAPSHOT
  • TABLE 103.THERMO FISHER: OPERATING SEGMENTS

LIST OF FIGURES

  • FIGURE 01.3D CELL CULTURE MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2020*
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2017-2020* (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2020*
  • FIGURE 06.PATENTS REGISTERED/ APPROVED, BY YEAR (2011-2020)
  • FIGURE 07.PATENTS REGISTERED/ APPROVED, BY YEAR (2011-2020)
  • FIGURE 08.DRIVERS, RESTRAINTS AND OPPORTUNITY
  • FIGURE 09.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED PLATFORM, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 10.SCAFFOLD-BASED PLATFORM MARKET FOR MACRO-POROUS SCAFFOLDS, 2019 & 2027 ($MILLION)
  • FIGURE 11.SCAFFOLD-BASED PLATFORM MARKET FOR MICRO-POROUS SCAFFOLDS, 2019 & 2027 ($MILLION)
  • FIGURE 12.SCAFFOLD-BASED PLATFORM MARKET FOR NANO-POROUS SCAFFOLDS, 2019 & 2027 ($MILLION)
  • FIGURE 13.SCAFFOLD-BASED PLATFORM MARKET FOR SOLID SCAFFOLDS, 2019 & 2027 ($MILLION)
  • FIGURE 14.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE PLATFORM, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR GELS, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 16.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR MICROCHIPS, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR SERVICES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 21.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 22.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 23.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 24.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 25.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 26.CANCER SURVIVOR PREDICTIONS IN U.S.
  • FIGURE 27.CANCER INCIDENCES IN GERMANY (2007 & 2050)
  • FIGURE 28.AVANTOR: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 29.AVANTOR: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 30.AVANTOR: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 31.BD: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 32.BD: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 33.BD: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 34.CORNING: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 35.CORNING: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 36.CORNING: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 37.LONZA: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 38.LONZA: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 39.LONZA: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 40.MERCK: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 41.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 42.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 43.THERMO FISHER: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 44.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 45.THERMO FISHER: REVENUE SHARE BY REGION, 2019 (%)
目次
Product Code: A01155

Title:
3D Cell Culture Market by Product (Scaffold-Based Platforms, Scaffold-Free Platforms, Gels, Bioreactors, Microchips, and Services), Application (Cancer Research, Stem Cell Research, Drug Discovery, and Regenerative Medicine), and End User (Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2027.

Cell culture is a significant tool in biological research. These cultures are mainly of two types, namely two-dimensional (2D) and three-dimensional (3D). Since the advent of cell culture techniques, 2D cell cultures are mostly preferred due to their availability, ease of environmental control, cell observation and measurement. However, growing cells in flat layers on surfaces do not precisely model the in-vivo state. As compared to 2D, 3D cell culture permits the biological cells to grow and interact with their surroundings in all three dimensions. Cells grown in a 3D cell culture models have proven to be physiologically relevant. They have shown improvements in numerous studies of biological mechanisms including cell morphology, proliferation, differentiation, cell number monitoring, viability, migration & invasion of tumor cells into surrounding tissues, response to stimuli, angiogenesis stimulation, drug metabolism, gene expression & protein synthesis, immune system evasion, and in-vivo relevance. Thus, 3D cell cultures are beneficial in studying and analyzing the etiology of diseases; thereby, facilitating their adoption in the field of research.

The global 3D cell culture market was evaluated at $1,234.86 million in 2019, and is estimated to garner $3,721.68 million by 2027, registering a CAGR of 16.3% during the forecast period. This growth rate is majorly attributed to the advantages offered by 3D cell cultures over conventional 2D cell cultures in cell-to-cell and cell-to-matrix interactions. In addition, continuous effort in R&D activities for drug discovery, development & screening and inclination toward the use of 3D cell cultures in cancer research are some other factors anticipated to propel the growth of the market over the analysis period. Likewise, surge in demand for organ transplantation is predicted to have a positive impact on the growth of 3D cell culture market. Conversely, higher costs associated with implementation of 3D cell cultures and inconsistent results are obstructing the market growth. On the other hand, upcoming technologies leading to product advancements in the field of 3D cell culture is estimated to provide profitable growth opportunities for the key market players in the market. Furthermore, the 3D cell culture industry is currently facing newer challenges to cope up with the demand and supply of 3D cell culture components owing to the COVID-19 pandemic. In addition, inconsistent and interrupted supply chain activities and availability of human resources are expected to impact the market growth. On the contrary, surge in research practices for developing novel therapies against COVID-19 is serving as a huge opportunity for the key market players. Research associated with stem cell therapies and regenerative medicine has shown promising results for treating the COVID-19 disease; thus, this is expected to compensate the deleterious impact caused by lockdowns globally. Thus, the overall COVID-19 impact is anticipated to remain moderate for the prominent players in the 3D cell culture market.

The research report categorizes the 3D cell culture market based on product, application, end user, and region. Based on product, the market is segmented into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips and services. Based on application, the 3D cell culture market is divided into cancer research, stem cell research, drug discovery, and regenerative medicine. The end user segment of the market comprises biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Region wise, the market has been analyzed across four regions namely, North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2027, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global 3D cell culture market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

  • By Product
  • Scaffold-Based Platforms
  • Macro-Porous Scaffolds
  • Micro-Porous Scaffolds
  • Nano-Porous Scaffolds
  • Solid Scaffolds
  • Scaffold-Free Platforms
  • Gels
  • Bioreactors
  • Microchips
  • Services
  • By Application
  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative Medicine
  • By End User
  • Biotechnology & Pharmaceutical Companies
  • Contract Research Laboratories
  • Academic Institutes
  • By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • 3D Biotek, LLC
  • Advanced Biomatrix, Inc.
  • Avantor, Inc.
  • Becton, Dickinson, and Company
  • Corning Incorporated
  • InSphero AG
  • Lonza Group Ltd.
  • Merck & Co., Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Patent analysis
    • 3.3.1.Patent analysis, by year
    • 3.3.2.Patent analysis, by country
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Advantages of 3D culture techniques over 2D techniques
      • 3.4.1.2.Growth in investments toward R&D activities
      • 3.4.1.3.Shift in preference toward 3D cell cultures for cancer research
      • 3.4.1.4.Upsurge in demand for organ transplantation
    • 3.4.2.Restraints
      • 3.4.2.1.Higher implementation costs
      • 3.4.2.2.Irregularity in 3D cell culture outcomes
    • 3.4.3.Opportunity
      • 3.4.3.1.Technological advancements
  • 3.5.COVID-19 Impact analysis

CHAPTER 4:3D CELL CULTURE MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Scaffold-based platform
    • 4.2.1.Key market trends and growth opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market analysis, by country
    • 4.2.4.Scaffold-based platform market, by type
      • 4.2.4.1.Macro-Porous Scaffolds
      • 4.2.4.1.1.Market size and forecast
      • 4.2.4.2.Micro-Porous Scaffolds
      • 4.2.4.2.1.Market size and forecast
      • 4.2.4.3.Nano-Porous Scaffolds
      • 4.2.4.3.1.Market size and forecast
      • 4.2.4.4.Solid Scaffolds
      • 4.2.4.4.1.Market size and forecast
  • 4.3.Scaffold-Free Platform
    • 4.3.1.Key market trends and growth opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country
  • 4.4.Gels
    • 4.4.1.Key market trends and growth opportunities
    • 4.4.2.Market size and forecast
    • 4.4.3.Market analysis, by country
  • 4.5.Bioreactors
    • 4.5.1.Key market trends and growth opportunities
    • 4.5.2.Market size and forecast
    • 4.5.3.Market analysis, by country
  • 4.6.Microchips
    • 4.6.1.Key market trends and growth opportunities
    • 4.6.2.Market size and forecast
    • 4.6.3.Market analysis, by country
  • 4.7.Services
    • 4.7.1.Key market trends and growth opportunities
    • 4.7.2.Market size and forecast
    • 4.7.3.Market analysis, by country

CHAPTER 5:3D CELL CULTURE MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Cancer research
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Stem cell research
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country
  • 5.4.Drug discovery
    • 5.4.1.Market size and forecast
    • 5.4.2.Market analysis, by country
  • 5.5.Regenerative medicine
    • 5.5.1.Market size and forecast
    • 5.5.2.Market analysis, by country

CHAPTER 6:3D CELL CULTURE MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Biotechnology & pharmaceutical companies
    • 6.2.1.Market size and forecast
    • 6.2.2.Market analysis, by country
  • 6.3.Contract research laboratories
    • 6.3.1.Market size and forecast
    • 6.3.2.Market analysis, by country
  • 6.4.Academic institutes
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country

CHAPTER 7:3D CELL CULTURE MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends and opportunities
    • 7.2.2.Market size and forecast, by country
    • 7.2.3.North America 3D cell culture market by product
    • 7.2.4.North America 3D cell culture market by application
    • 7.2.5.North America 3D cell culture market by end user
    • 7.2.6.U.S.
      • 7.2.6.1.U.S. 3D cell culture market by product
      • 7.2.6.2.U.S. 3D cell culture market by application
      • 7.2.6.3.U.S. 3D cell culture market by end user
    • 7.2.7.Canada
      • 7.2.7.1.Canada 3D cell culture market by product
      • 7.2.7.2.Canada 3D cell culture market by application
      • 7.2.7.3.Canada 3D cell culture market by end user
    • 7.2.8.Mexico
      • 7.2.8.1.Mexico 3D cell culture market by product
      • 7.2.8.2.Mexico 3D cell culture market by application
      • 7.2.8.3.Mexico 3D cell culture market by end user
  • 7.3.Europe
    • 7.3.1.Key market trends and opportunities
    • 7.3.2.Market size and forecast, by country
    • 7.3.3.Europe 3D cell culture market by product
    • 7.3.4.Europe 3D cell culture market by application
    • 7.3.5.Europe 3D cell culture market by end user
    • 7.3.6.Germany
      • 7.3.6.1.Germany 3D cell culture market by product
      • 7.3.6.2.Germany 3D cell culture market by application
      • 7.3.6.3.Germany 3D cell culture market by end user
    • 7.3.7.France
      • 7.3.7.1.France 3D cell culture market by product
      • 7.3.7.2.France 3D cell culture market by application
      • 7.3.7.3.France 3D cell culture market by end user
    • 7.3.8.UK
      • 7.3.8.1.UK 3D cell culture market by product
      • 7.3.8.2.UK 3D cell culture market by application
      • 7.3.8.3.UK 3D cell culture market by end user
    • 7.3.9.Rest of Europe
      • 7.3.9.1.Rest of Europe 3D cell culture market by product
      • 7.3.9.2.Rest of Europe 3D cell culture market by application
      • 7.3.9.3.Rest of Europe 3D cell culture market by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends and opportunities
    • 7.4.2.Market size and forecast, by country
    • 7.4.3.Asia-Pacific 3D cell culture market by product
    • 7.4.4.Asia-Pacific 3D cell culture market by application
    • 7.4.5.Asia-Pacific 3D cell culture market by end user
    • 7.4.6.Japan
      • 7.4.6.1.Japan 3D cell culture market by product
      • 7.4.6.2.Japan 3D cell culture market by application
      • 7.4.6.3.Japan 3D cell culture market by end user
    • 7.4.7.China
      • 7.4.7.1.China 3D cell culture market by product
      • 7.4.7.2.China 3D cell culture market by application
      • 7.4.7.3.China 3D cell culture market by end user
    • 7.4.8.India
      • 7.4.8.1.India 3D cell culture market by product
      • 7.4.8.2.India 3D cell culture market by application
      • 7.4.8.3.India 3D cell culture market by end user
    • 7.4.9.Australia
      • 7.4.9.1.Australia 3D cell culture market by product
      • 7.4.9.2.Australia 3D cell culture market by application
      • 7.4.9.3.Australia 3D cell culture market by end user
    • 7.4.10.Rest of Asia-Pacific
      • 7.4.10.1.Rest of Asia-Pacific 3D cell culture market by product
      • 7.4.10.2.Rest of Asia-Pacific 3D cell culture market by application
      • 7.4.10.3.Rest of Asia-Pacific 3D cell culture market by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends and opportunities
    • 7.5.2.Market size and forecast, by country
    • 7.5.3.LAMEA 3D cell culture market by product
    • 7.5.4.LAMEA 3D cell culture market by application
    • 7.5.5.LAMEA 3D cell culture market by end user
    • 7.5.6.Brazil
      • 7.5.6.1.Brazil 3D cell culture market by product
      • 7.5.6.2.Brazil 3D cell culture market by application
      • 7.5.6.3.Brazil 3D cell culture market by end user
    • 7.5.7.Saudi Arabia
      • 7.5.7.1.Saudi Arabia 3D cell culture market by product
      • 7.5.7.2.Saudi Arabia 3D cell culture market by application
      • 7.5.7.3.Saudi Arabia 3D cell culture market by end user
    • 7.5.8.South Africa
      • 7.5.8.1.South Africa 3D cell culture market by product
      • 7.5.8.2.South Africa 3D cell culture market by application
      • 7.5.8.3.South Africa 3D cell culture market by end user
    • 7.5.9.Rest of LAMEA
      • 7.5.9.1.Rest of LAMEA 3D cell culture market by product
      • 7.5.9.2.Rest of LAMEA 3D cell culture market by application
      • 7.5.9.3.Rest of LAMEA 3D cell culture market by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.3D BIOTEK LLC
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Business performance
  • 8.2.ADVANCED BIOMATRIX, INC.
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Business performance
    • 8.2.5.Key strategic moves and developments
  • 8.3.AVANTOR, INC.
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Business performance
  • 8.4.BECTON, DICKINSON AND COMPANY
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Business performance
  • 8.5.CORNING INCORPORATED
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Business performance
    • 8.5.5.Key strategic moves and developments
  • 8.6.INSPHERO AG
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Business performance
    • 8.6.5.Key strategic moves and developments
  • 8.7.LONZA GROUP LTD.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Business performance
    • 8.7.5.Key strategic moves and developments
  • 8.8.MERCK & CO., INC.
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Business performance
  • 8.9.SYNTHECON, INCORPORATED
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Business performance
  • 8.10.THERMO FISHER SCIENTIFIC INC.
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Business performance